Lexaria Bioscience Corp. (LEXX)
2.93
+0.16
(+5.78%)
USD |
NASDAQ |
Oct 06, 13:23
Lexaria Bioscience Cash from Investing (Quarterly) : -0.0271M for May 31, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.0271M |
| February 28, 2026 | -0.0539M |
| November 30, 2025 | -0.0051M |
| August 31, 2025 | -0.1579M |
| May 31, 2025 | -0.0194M |
| February 28, 2025 | -0.0279M |
| November 30, 2024 | -0.0378M |
| August 31, 2024 | -0.0696M |
| May 31, 2024 | -0.022M |
| February 29, 2024 | -0.057M |
| November 30, 2023 | -0.04M |
| August 31, 2023 | |
| May 31, 2023 | -0.0336M |
| February 28, 2023 | -0.0327M |
| November 30, 2022 | -0.0348M |
| August 31, 2022 | -0.05M |
| May 31, 2022 | -0.038M |
| February 28, 2022 | -0.0344M |
| November 30, 2021 | -0.0582M |
| August 31, 2021 | 0.00 |
| May 31, 2021 | -0.0707M |
| February 28, 2021 | 0.2704M |
| November 30, 2020 | -0.0058M |
| August 31, 2020 | -0.0136M |
| May 31, 2020 | -0.0075M |
| Date | Value |
|---|---|
| February 29, 2020 | 0.00 |
| November 30, 2019 | -0.0057M |
| August 31, 2019 | -0.0331M |
| May 31, 2019 | -1.239M |
| February 28, 2019 | 0.6703M |
| November 30, 2018 | -0.1672M |
| August 31, 2018 | -0.0268M |
| May 31, 2018 | -0.0266M |
| February 28, 2018 | -0.0163M |
| November 30, 2017 | -0.0857M |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.004M |
| November 30, 2016 | -0.0137M |
| August 31, 2016 | -0.0047M |
| May 31, 2016 | -0.0003M |
| February 29, 2016 | -0.012M |
| November 30, 2015 | -0.0031M |
| August 31, 2015 | 0.004M |
| May 31, 2015 | -0.041M |
| February 28, 2015 | 0.7218M |
| November 30, 2014 | 0.00 |
| October 31, 2014 | |
| July 31, 2014 | -0.0516M |
| April 30, 2014 | -0.0314M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | -0.0065M |
| InMed Pharmaceuticals, Inc. | 0.00 |
| XORTX Therapeutics, Inc. | -0.1388M |
| NervGen Pharma Corp. | -0.0001M |
| Milestone Pharmaceuticals, Inc. | 111.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.635M |
| Free Cash Flow | -7.527M |
| Free Cash Flow Per Share (Quarterly) | -1.005 |
| Free Cash Flow to Equity (Quarterly) | -1.654M |
| Free Cash Flow to Firm (Quarterly) | -1.661M |
| Free Cash Flow Yield | -170.9% |